Our findings suggest that non-coding ribonucleic acids (ncRNAs)-mediated upregulation of MAD2L1 is associated with poor prognosis and tumor immune infiltration in HCC patients. The gene discussed is MAD2L1; the disease is hepatocellular carcinoma.